Latest From Biotech Now

BIO releases largest study ever on clinical development success rates

On Wednesday, BIO released the largest ever study of clinical development success rates. The study, conducted in partnership with Amplion and Biomedtracker, recorded and analyzed 9,985 clinical and regulatory phase transitions, across 1,103 companies. Using clinical trial data from the past decade, “Clinical Development Success Rates 2006-2015” compares groups of diseases, drug modalities and other attributes to generate the most comprehensive analysis, to date, of biopharmaceutical R&D success. “This study provides a wealth of information about drug development success rates Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , ,

A Closer Look at AHIP’s Claims

new-bio-logo

This morning, in a letter to the editor of the New York Times, Marilyn Tavenner, President and CEO of America’s Health Insurance Plans (AHIP), attempted to lay the blame for higher healthcare costs and insurance premiums at the feet of America’s cutting-edge biopharma companies. AHIP has been peddling these falsehoods and misinformation for years.  Tavenner’s (and her organization’s) claims are—at best—uninformed. At worst, they are outright distortions deployed to hide the facts from patients who Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Food Waste: Can Biotech Play a Role?

Food waste

“40% of food grown in U.S. is wasted.” – House Ag Commitee Chairman Conaway On Wednesday, May 25, 2016, the House Committee on Agriculture held a hearing to examine what voluntary efforts can be done to address the issue of food waste. The hearing was titled Food Waste from Field to Table and witnesses included Rep. Chellie Pingree (D-Maine), along with several other experts on the issue. Ms. Dana Gunders, Senior Scientist, Food & Agriculture Program, National Resources Defense Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Incentivizing Exponential Approaches to Energy and Climate

carbon_xprize_logo

Biotech may be the 21st century’s greatest opportunity. Climate change and energy transformation may be its greatest challenge. The NRG COSIA Carbon XPRIZE intends to bring the opportunity of biotech to this challenge—it is a call to action to all scientists, engineers, entrepreneurs, and innovators to demonstrate and inspire a path to a better energy future. Biotech is rapidly blurring the lines between the impossible and the possible. The exponential pace of technological advances makes Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO 2016 Patient Pavilion Snapshot: Alpha-1 Project

Alpha1Project

Every year, the BIO International Convention brings together stakeholders from the health care community to discuss how we can accelerate the pace of innovation to bring new, effective treatments to patients.  In recent years, the patient voice has been amplified in the drug development process as new models for collaboration are emerging to advance therapeutic development and ensure new treatments have meaningful outcomes for patients.  To help amplify that voice at the BIO International Convention, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,